WRN Western meets Q4 2025 analyst EPS estimates registers modest share gains following earnings release How Federal FSS thinks about risk management Q1 2026 EPS Exceeds Expectations MSA Safety MSA posts 43 percent Q4 2025 EPS surprise yet shares edge 036 percent lower in todays trading Regeneron Pharmaceuticals Inc REGN Bullish Analyst Ratings Underscore Oncology Pipeline Upside and Core Product Resilience